Shardul Amarchand Mangaldas Advises Biocon on USD 1.2 Billion Acquisition of Minority Shares in Biocon Biologics

Shardul Amarchand Mangaldas & Co. advised Biocon Limited and its subsidiary Biocon Biologics Limited in the transaction. New Delhi | December 10th, 2025: The firm advised Biocon Limited (BL) and Biocon Biologics Limited (BBL) on an integration transaction of approximately USD 1.2 billion, under which BL acquired minority shareholdings in BBL. The acquisition involved the purchase of stakes from Viatris, Serum Institute Lifesciences, Tata Capital Growth Fund II and True North. Shardul Amarchand Mangaldas & Co. represented Biocon Limited and Biocon Biologics Limited with a team composed by: Transaction Team led by Raghubir Menon, Partner and Regional Practice Head – Mumbai, M&A and Private Equity, General Corporate; and Natashaa Shroff, Partner; along with Tarumoy Chaudhuri, Partner; Rounak Agarwal, Principal Associate; Kriti Saraswat, Senior Associate; Sohini Banerjee, Associate; Mihira Jaggi, Associate; and Anushya Ramakrishna, Associate. Shardul Amarchand Mangaldas & Co. represented Biocon Limited and Biocon Biologics Limited with a team composed by: Competition Team led by Shweta Shroff Chopra, Partner, and Supritha Prodaturi, Partner, supported by Parinita Kare, Senior Associate; Vasudha Verma, Associate; Saii S., Associate; and Janhavi Jyoti S., Associate. Shardul Amarchand Mangaldas & Co. represented Biocon Limited and Biocon Biologics Limited with a team composed by: Capital Markets Team including Prashant Gupta, Partner – National Practice Head – Capital Markets; Ruth Chenchiah, Partner; and Debolina Mitra, Senior Associate. Shardul Amarchand Mangaldas & Co. represented Biocon Limited and Biocon Biologics Limited with a team composed by: Banking & Finance Team comprising Shubhangi Garg, Partner, and Ansh Jain, Associate. Shardul Amarchand Mangaldas & Co. represented Biocon Limited and Biocon Biologics Limited with a team composed by: Securities Team including Yogesh Chande, Partner, and Anushri Mandal, Associate.

Shardul Amarchand Mangaldas Advises Biocon on USD 1.2 Billion Acquisition of Minority Shares in Biocon Biologics

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads